Company Performance - High Tide Inc. (HITI) shares have increased by 14% over the past month and reached a new 52-week high of 0.01 in its last earnings report on September 16, 2024, surpassing the consensus estimate of 0.04 per share on revenues of $380.89 million, with a projected year-over-year earnings growth of 450% [3] Valuation Metrics - High Tide has a Value Score of A, a Growth Score of A, and a Momentum Score of F, resulting in a combined VGM Score of A [6] - The stock currently trades at 93.1X current fiscal year EPS estimates, which is a premium compared to the peer industry average of 26.7X [6] - On a trailing cash flow basis, High Tide trades at 12.6X, slightly above the peer group's average of 12.5X [6] Zacks Rank - High Tide holds a Zacks Rank of 2 (Buy), supported by favorable earnings estimate revisions from analysts [7] - The recommendation for investors is to select stocks with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, indicating that High Tide fits this criterion [7] Industry Comparison - The Medical - Products industry is performing well, ranking in the top 32% of all industries, providing a favorable environment for both High Tide and its peer, Phibro Animal Health Corporation (PAHC) [10] - PAHC has a Zacks Rank of 2 (Buy) and has shown strong earnings performance, beating consensus estimates by 52.17% last quarter [9]
High Tide Inc. (HITI) Hit a 52 Week High, Can the Run Continue?